Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Salmon calcitonin in hypercalcemia.

L A Wisneski, W P Croom, O L Silva

Clinical Pharmacology and Therapeutics

|August 1, 1978

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Th2 and Th9 responses in patients with chronic mucocutaneous candidiasis and hyper-IgE syndrome.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2016

Same author

Editorials.

Postgraduate medicine·2016

Same author

Aspergillus Cell Wall Chitin Induces Anti- and Proinflammatory Cytokines in Human PBMCs via the Fc-γ Receptor/Syk/PI3K Pathway.

mBio·2016

Same author

Salivary and serum procalcitonin and C-reactive protein as biomarkers of periodontitis in United States veterans with osteoarthritis or rheumatoid arthritis.

Biotechnic & histochemistry : official publication of the Biological Stain Commission·2016

Same author

Pattern recognition pathways leading to a Th2 cytokine bias in allergic bronchopulmonary aspergillosis patients.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2014

Same author

Is nitric oxide a mediator of the effects of low-intensity electrical stimulation on bone in ovariectomized rats?

Calcified tissue international·2010

Salmon calcitonin effectively reduces serum calcium in hypercalcemic patients, often to tolerable levels. This therapeutic agent was well-tolerated, with minimal side effects, and showed promise for managing hypercalcemia.

Area of Science:

Endocrinology
Pharmacology

Background:

Hypercalcemia is a condition characterized by elevated serum calcium levels.
Effective management of hypercalcemia is crucial for patient well-being and preventing complications.

Purpose of the Study:

To evaluate the efficacy and safety of salmon calcitonin in treating hypercalcemic patients.
To assess the impact of salmon calcitonin on serum calcium levels and patient symptoms.

Main Methods:

A study involving 24 hypercalcemic patients.
Administration of salmon calcitonin as a therapeutic agent.
Monitoring of serum calcium levels and patient-reported symptoms.

Main Results:

75% of patients showed a significant decrease in serum calcium.

Related Experiment Videos

Approximately 50% of patients became normocalcemic within 2 hours.

Symptomatic improvement was observed in many patients.

Nausea and vomiting occurred in 12.5% of patients, with only one requiring cessation of therapy.

The drug was well-tolerated in patients with azotemia.

Conclusions:

Salmon calcitonin is an effective and safe therapeutic agent for managing hypercalcemia.
It can be used alone or in combination with other hypocalcemic therapies.
The drug offers a favorable safety profile with manageable side effects.